Table:
Saline control	Bevacizumab treatment
Pre	Post	Pre	Post
Tumor volume, range (mm3)	7.34–36.9	9.20–58.2	6.96–46.8	8.13–44.5
Tumor volume, mean ± sd (mm3)	14.7 ± 9.4	22.7 ± 15.7	16.1 ± 13.2	17.8 ± 12.3
R1, range (ms–1)	0.45–0.54	0.42–0.55	0.45–0.57	0.49–0.59
R1, mean ± sd (ms–1)	0.53 ± 0.03	0.50 ± 0.04	0.53 ± 0.04	0.54 ± 0.04
Steady-state rCBV, range	0.76–2.89	0.63–1.63	0.92–1.61	0.63–1.55
Steady-state rCBV, mean ± sd	1.45 ± 0.83	1.17 ± 0.45	1.20 ± 0.26	0.93 ± 0.26
Ktrans, range (min–1)	0.027–0.084	0.026–0.084	0.016–0.064	0.014–0.054
Ktrans, mean ± sd (min–1)	0.047 ± 0.018	0.056 ± 0.018	0.043 ± 0.016	0.031 ± 0.014

Parse the picture content behind with markdown code: |  | <COLSPAN=2> Saline control | <COLSPAN=2> Bevacizumab treatment | 
 |  | Pre | Post | Pre | Post | 
 | --- | --- | --- | --- | --- | 
 | Tumor volume, range (mm3) | 7.34–36.9 | 9.20–58.2 | 6.96–46.8 | 8.13–44.5 | 
 | Tumor volume, mean ± sd (mm3) | 14.7 ± 9.4 | 22.7 ± 15.7 | 16.1 ± 13.2 | 17.8 ± 12.3 | 
 | R1, range (ms–1) | 0.45–0.54 | 0.42–0.55 | 0.45–0.57 | 0.49–0.59 | 
 | R1, mean ±

sd (ms–1) | 0.53 ± 0.03 | 0.50 ± 0.04 | 0.53 ± 0.04 | 0.54 ± 0.04 | 
 | Steady-state rCBV, range | 0.76–2.89 | 0.63–1.63 | 0.92–1.61 | 0.63–1.55 | 
 | Steady-state rCBV, mean ± sd | 1.45 ± 0.83 | 1.17 ± 0.45 | 1.20 ± 0.26 | 0.93 ± 0.26 | 
 | Ktrans, range (min–1) | 0.027–0.084 | 0.026–0.084 | 0.016–0.064 | 0.014–0.054 | 
 | Ktrans, mean ± sd (min–1) | 0.047 ± 0.018 | 0.056 ± 0.018 | 0.043 ± 0.016 | 0.031 ± 0.014 |